Aug 2026
Microvascular resistance reserve and cardiovascular outcomes: the FLOW-CMD registry.
Seung-Hun Lee, J. Ahn, W. Jones et al.
· European Heart Journal · 0 citations
3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Sep 2026
Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial.
BACKGROUND Clopidogrel has emerged as a promising alternative to aspirin monotherapy for maintenance therapy after percutaneous coronary intervention (PCI); however, the optimal antiplatelet strategy according to sex remains controversial. AIMS We aimed to investigate whether the treatment effect of antiplatelet ther...
Woo-Duk Kwon, Ki H. Choi, Yonghwan Park et al.
· EuroIntervention · 0 citations
Review
Aug 2026
Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.
In stable patients with previous myocardial infarction, left ventricular ejection fraction ≥40%, no heart failure, and no other indication for β-blocker therapy, discontinuation met the non-inferiority criteria for the primary and key secondary endpoints.
J. Silvain, Ki H. Choi, Victorien Monguillon et al.
· The Lancet · 1 citation